178 related articles for article (PubMed ID: 10569932)
1. DNA abasic lesions in a different light: solution structure of an endogenous topoisomerase II poison.
Cline SD; Jones WR; Stone MP; Osheroff N
Biochemistry; 1999 Nov; 38(47):15500-7. PubMed ID: 10569932
[TBL] [Abstract][Full Text] [Related]
2. Apurinic sites are position-specific topoisomerase II poisons.
Kingma PS; Osheroff N
J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
[TBL] [Abstract][Full Text] [Related]
3. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions.
Sabourin M; Osheroff N
Nucleic Acids Res; 2000 May; 28(9):1947-54. PubMed ID: 10756196
[TBL] [Abstract][Full Text] [Related]
5. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
7. Base excision repair intermediates as topoisomerase II poisons.
Wilstermann AM; Osheroff N
J Biol Chem; 2001 Dec; 276(49):46290-6. PubMed ID: 11591703
[TBL] [Abstract][Full Text] [Related]
8. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
[TBL] [Abstract][Full Text] [Related]
9. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
[TBL] [Abstract][Full Text] [Related]
10. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
11. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
[TBL] [Abstract][Full Text] [Related]
13. Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions.
Li TK; Bathory E; LaVoie EJ; Srinivasan AR; Olson WK; Sauers RR; Liu LF; Pilch DS
Biochemistry; 2000 Jun; 39(24):7107-16. PubMed ID: 10852708
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
Fortune JM; Osheroff N
Prog Nucleic Acid Res Mol Biol; 2000; 64():221-53. PubMed ID: 10697411
[TBL] [Abstract][Full Text] [Related]
15. Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage.
Bromberg KD; Burgin AB; Osheroff N
Biochemistry; 2003 Apr; 42(12):3393-8. PubMed ID: 12653542
[TBL] [Abstract][Full Text] [Related]
16. Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes.
Shea ME; Hiasa H
Nucleic Acids Res; 2001 Feb; 29(3):614-21. PubMed ID: 11160881
[TBL] [Abstract][Full Text] [Related]
17. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
Felix CA; Lange BJ; Hosler MR; Fertala J; Bjornsti MA
Cancer Res; 1995 Oct; 55(19):4287-92. PubMed ID: 7671237
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
Kingma PS; Greider CA; Osheroff N
Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].
Vashisht Gopal YN; Konuru N; Kondapi AK
Arch Biochem Biophys; 2002 May; 401(1):53-62. PubMed ID: 12054487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
